Studies outside the US in the post–COVID-19 pandemic period (ie, 2020 to the present) have demonstrated a shift in epidemiologic characteristics of the respiratory syncytial virus (RSV) season. For example, delayed RSV seasons have been observed in France,
1,2 Germany,
3 Finland,
4 Israel,
5 and England,
6 as well as in the Southern Hemisphere, including in Argentina,
7 South Africa,
8 and Australia.
9,10 In 1 study, a delayed onset of the first postpandemic RSV season was reported in 11 countries, including South Korea, Canada, Chile, Brazil, and the US, among others.
11 Nonpharmaceutical interventions (NPIs) are generally attributed internationally for the delayed RSV resurgences.
1,4,9,10,12-17